WisdomTree BioRevolution Fund (BATS:WDNA – Get Free Report)’s stock price dropped 0.3% during mid-day trading on Thursday . The company traded as low as $23.84 and last traded at $23.84. 424 shares traded hands during mid-day trading, a decline of 66% from the average daily volume of 1,239 shares. The stock had previously closed at $23.90.
WisdomTree BioRevolution Fund Trading Down 2.7%
The company has a market cap of $3.48 million, a PE ratio of 17.03 and a beta of 1.01. The company has a fifty day simple moving average of $20.89 and a two-hundred day simple moving average of $18.88.
Institutional Inflows and Outflows
An institutional investor recently raised its position in WisdomTree BioRevolution Fund stock. Jane Street Group LLC grew its position in WisdomTree BioRevolution Fund (BATS:WDNA – Free Report) by 45.9% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 16,864 shares of the company’s stock after purchasing an additional 5,306 shares during the quarter. Jane Street Group LLC owned approximately 11.24% of WisdomTree BioRevolution Fund worth $231,000 at the end of the most recent reporting period.
About WisdomTree BioRevolution Fund
The WisdomTree BioRevolution Fund (WDNA) is an exchange-traded fund that is based on the WisdomTree BioRevolution index. The fund tracks a modified equally-weighted index of companies in developed markets that focus on the advancements in genetics and biotechnology. WDNA was launched on Jun 3, 2021 and is managed by WisdomTree.
Read More
- Five stocks we like better than WisdomTree BioRevolution Fund
- Venture Into High-Volatility Corners of the Market With These 3 ETFs
- 3 Retail Stocks to Watch After a Big Consumer Earnings Week
- Amazon’s Zoox Push Tests Tesla’s Robotaxi Premium as Waymo Widens Its Lead
- MarketBeat Week in Review – 08/24 – 08/28
Receive News & Ratings for WisdomTree BioRevolution Fund Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for WisdomTree BioRevolution Fund and related companies with MarketBeat.com's FREE daily email newsletter.
